Please login to the form below

Not currently logged in
Email:
Password:

Atlas Genetics appoints Jeffery Luber as CEO

Former CEO Dr John Clarkson will move into an executive chairman position

Atlas Genetics has appointed its new chief executive officer in the form of Jeffrey Luber, as he succeeds Dr John Clarkson who transitions into executive chairman.

Luber also joins the company’s board following experience in the life sciences industry and holding multiple leadership roles including CEO of EXACT Sciences.

He said: “I am thrilled to join Atlas Genetics given the power of its platform, the strength of its board and leadership team, and its experience investor syndicate.

“As diagnostic testing increasingly becomes more decentralised, I look forward to working with the team to make Atlas the leading global player in POC testing.”

Prior to his new role at Atlas, Luber most recently led the return to growth and sale of Good Start Genetics to Invitae Corp, producing strategic partnerships with Roche Diagnostics and Amazon.

Dr John Clarkson, founding CEO, Atlas Genetics, said: “Jeff’s proven track record and extensive experience in the commercialisation of in vitro diagnostics will be invaluable as we enter the next, exciting phase of growth aimed at improving the diagnosis and treatment of conditions affecting women and families.”

11th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
So how do you really engage with patients?
The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...
data
Avoiding data pitfalls in clinical research
Genomics sequencing and sensors will present new challenges...

Infographics